Founded with a vision to redefine pharmaceutical research and development, DAISA BIOPHARMA stands as a beacon of innovation and quality in the industry. Our integrated approach combines Medicinal Chemistry, Process Chemistry, and Biocatalysis to address complex challenges in drug discovery and development.
With a focus on scientific rigor and operational excellence, we support pharmaceutical companies, biotech firms, and research organizations by offering tailored, scalable, and regulatory-compliant solutions. From ideation to implementation, DAISA BIOPHARMA is your strategic partner in creating life-changing therapeutics.
Our Core Service Areas:
Design of novel chemical entities (NCEs) in collaboration with in silico molecular modeling.
Synthesis of NCEs and optimization of pharmaceutically acceptable salts and pro-drugs for enhanced solubility, bioavailability, and efficacy.
Creation of natural product-inspired molecular libraries for innovative drug discovery.
QbD-based API development ensuring safety, scalability, and cost-effectiveness.
Synthetic route scouting to develop novel, non-infringing, faster, and safer synthesis routes.
Process optimization focusing on critical parameters, reaction conditions, and reagent quantities for maximum efficiency.
Comprehensive CMC and DMF support.
Expertise in high potent API synthesis, salt screening, impurity synthesis, and polymorph optimization.
Enzyme screening for biocatalysis applications.
Enzymatic and whole-cell bioconversion processes for sustainable and efficient production.
Scale-up services for industrial-scale bioconversion processes.
At DAISA BIOPHARMA, we don't just develop molecules โ we help create healthier futures.